Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form

被引:113
作者
Talley, NJ [1 ]
Verlinden, M
Jones, M
机构
[1] Univ Sydney, Nepean Hosp, Dept Med, Penrith, NSW 2751, Australia
[2] Abbott Labs, Abbott Pk, IL 60064 USA
关键词
D O I
10.1046/j.1365-2036.2001.00900.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The Nepean Dyspepsia Index is a reliable and valid measure of quality of life in functional dyspepsia, but responsiveness has been little studied. The Nepean Dyspepsia Index originally contained 42 items designed to measure impairment of a subject's ability to engage in relevant aspects of their life because of dyspepsia, and their enjoyment of these aspects; in addition, the individual importance of areas was assessed. It was subsequently shortened to 25 items, yielding five sub-scales. Aim: To test the Nepean Dyspepsia Index's responsiveness and develop a responsive, very short form. Methods: A randomized, double-blind controlled trial was performed in 589 patients with documented functional dyspepsia. Symptoms and quality of life were measured at baseline, 2 and 4 weeks. Responsiveness of the Nepean Dyspepsia Index quality-of-life section was evaluated by correlation with symptom scores and calculation of standardized changes in scores. Two items from each sub-scale which best represented the area of life (by factor loadings) were selected to create the 10-item short form (SF; short form-Nepean Dyspepsia Index). Internal consistency was assessed by Cronbach's alpha and responsiveness was assessed as above. Results: The Nepean Dyspepsia Index quality-of-life scales demonstrated excellent responsiveness to change in both the active and placebo arms (standardized response means all > 1.0). The Nepean Dyspepsia Index accounted for only 8% of the variance in percentage change in symptoms (by visual analogue scales), indicating that it was evaluating areas of life not covered by symptoms. The 10-item short form had adequate internal consistency (all scales greater than or equal to 0.70) and all strongly (and significantly) correlated with the long form sub-scales; it was also highly responsive. Conclusion: The Nepean Dyspepsia Index is a responsive disease-specific quality-of-life measure; the 10-item short form can be applied in clinical trials of functional dyspepsia.
引用
收藏
页码:207 / 216
页数:10
相关论文
共 23 条
[11]   RESPONSIVENESS AND VALIDITY IN HEALTH-STATUS MEASUREMENT - A CLARIFICATION [J].
GUYATT, GH ;
DEYO, RA ;
CHARLSON, M ;
LEVINE, MN ;
MITCHELL, A .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (05) :403-408
[12]   MEASURING HEALTH-RELATED QUALITY-OF-LIFE [J].
GUYATT, GH ;
FEENY, DH ;
PATRICK, DL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (08) :622-629
[13]   Clinical economics review: Gastrointestinal disease in primary care [J].
Jones, RH .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (03) :233-239
[14]  
Shaw M, 1998, ALIMENT PHARM THERAP, V12, P1067
[15]   GSRS - A CLINICAL RATING-SCALE FOR GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PEPTIC-ULCER DISEASE [J].
SVEDLUND, J ;
SJODIN, I ;
DOTEVALL, G .
DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (02) :129-134
[16]  
Talley NJ, 1999, AM J GASTROENTEROL, V94, P2390
[17]   IMPACT OF FUNCTIONAL DYSPEPSIA ON QUALITY-OF-LIFE [J].
TALLEY, NJ ;
WEAVER, AL ;
ZINSMEISTER, AR .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (03) :584-589
[18]   A CRITIQUE OF THERAPEUTIC TRIALS IN HELICOBACTER-PYLORI - POSITIVE FUNCTIONAL DYSPEPSIA [J].
TALLEY, NJ .
GASTROENTEROLOGY, 1994, 106 (05) :1174-1183
[19]   Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial [J].
Talley, NJ ;
Verlinden, M ;
Snape, W ;
Beker, JA ;
Ducrotte, P ;
Dettmer, A ;
Brinkhoff, H ;
Eaker, E ;
Ohning, G ;
Miner, PB ;
Mathias, JR ;
Fumagalli, I ;
Staessen, D ;
Mack, RJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (12) :1653-1661
[20]  
TALLEY NJ, IN PRESS AM J GASTRO